NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Listen, I am no stranger to injectables and in-office treatments. In the last few years, I've tried lip ...
Woman’s ‘Kybella’ Face Transformation Stuns People After Her Extreme Recovery Phase Goes Viral
Excess fat under the chin can be a source of insecurity for many people. Even with a healthy lifestyle, this stubborn area is often resistant to diet and exercise, leading some to seek cosmetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback